Instead, when IM was diagnosed, individuals carrying the HLA‐E*01:01 allele had a significantly increased MS risk, with a proportion of combined risk attributable to interaction effects between HLA‐E*01:01 and IM estimated around 40% in heterozygotes and 65% in homozygotes [30]. The gene discussed is HLA-E; the disease is myeloid sarcoma.